Disclosure Insight
Contributor since: 2011
Company: Disclosure Insight
Catalyst Health Solutions Loses Third General Counsel Amid Recent History Of Leadership Turnover
In The Midst Of Beating The Street On 4Q11 Earnings, Janus Capital Group Discloses Upcoming Chairman Departure
Upcoming Director Departures At Schlumberger Will Bring Tally To Nine Departures Since 2007
Companies With Risk Of Undisclosed SEC Probes
Briggs & Stratton Announces Upcoming Restructuring And Impairment Charges
Is Roche Overpaying For Illumina?
Ecolab Announces More Restructuring Charges
MDCO Reaches Settlement With APP Pharmaceuticals, But Legal Issues Not Over Yet
Companies With Risk of Undisclosed SEC Probes
Despite Recent Settlement with U.S. Attorney, SYK Still Plauged by Ongoing Regulatory Investigations
Kinross Gold Corporation’s Expected Write-down Resembles Charge From 2008
Today's DI Reports
VMC Receives CID and Request for Additional Information from the DOJ
Newport Corp. Completes Acquisition of ILX - Caps $269 Million of Acquisitions Over Last 6 Months
ADM Announces Upcoming Restructuring and Impairment Charges - Adds to a History of One-time Items
USEC Discloses Impairment Charges and Possibility of More to Come
Medivation’ s Dimebon Fails in Third Study - Company Now Solely Reliant on MDV3100
IGT to Acquire Double Down - Position Itself to Take Advantage of Recent DOJ Gambling Opinion
Acacia Research Separates the Roles of Chairman and CEO - A Positive Move for a Company with Management and Board Stability
Regions Reaches Agreement to Divest Morgan Keegan - Retains Legal Liabilities
Acxiom Continues to See Turnover in the Executive Suite - Names Fifth CFO
Update: SQNM Faces Further Patent Litigation
Long Time HMA General Counsel Quietly Resigns Amidst Challenging Legal and Regulatory Environment
PHH CEO Resigns, Increases Count to 4 CEOs, 3 CFOs, and 7 Director Departures since 2008
Sanctions Imposed on Church & Dwight's CEO
LIZ Appoints Third CFO since Mid-2007 - Also Cuts 2012 Guidance
IPCM Off More than 30% on Estimated Results - Lingering Regulatory Investigation Still an Issue
Bristol-Myers Signs Agreement to Acquire Inhibitex for 160% Premium
Restructuring Charges Continue at Alcoa
New CFO Headlines a Series of Executive Suite Changes at Geron
ISIS Diversifies Concentrated Revenue Sources with Biogen Idec Agreement
Companies With Risk of Undisclosed SEC Probes